Doctors thought this kidney drug helped some patients. It may help millions more.
New studies show that the kidney drug finerenone may benefit more people than previously believed, including those with non-diabetic kidney disease. The drug was found to slow kidney function decline, reduce risks of kidney failure, heart failure, and death, and lower protein levels in the urine. These findings suggest finerenone could be a valuable treatment for a broader range of patients with chronic kidney disease. The results were published in three major medical journals after being presented at a leading international conference.
A kidney drug called finerenone may help more people than previously thought, including those with non-diabetic kidney disease.
This drug could save millions of lives by slowing kidney disease progression and reducing risks of heart failure and death.
This discovery offers new hope for patients with limited treatment options and highlights the power of ongoing medical research.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.